Interleukin IL-6 and TNFα are included in Supplementary Table S1, because these are considered key pro-inflammatory cytokine biomarkers known to be increased in de novo patients with RA [37,38], although their values were below the concentration of the lowest calibrator for the majority of all samples, but were above the limit of detection. The gene discussed is IL6; the disease is rheumatoid arthritis.